Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin (2016 - 2025)

OptimizeRx (OPRX) has disclosed EBT Margin for 16 consecutive years, with 23.17% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1634.0% to 23.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.35% through Dec 2025, up 2739.0% year-over-year, with the annual reading at 6.35% for FY2025, 2739.0% up from the prior year.
  • EBT Margin hit 23.17% in Q4 2025 for OptimizeRx, up from 4.02% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 23.17% in Q4 2025 to a low of 49.2% in Q1 2023.
  • Historically, EBT Margin has averaged 14.99% across 5 years, with a median of 16.26% in 2023.
  • Biggest five-year swings in EBT Margin: tumbled -3973bps in 2023 and later soared 5068bps in 2025.
  • Year by year, EBT Margin stood at 3.07% in 2021, then plummeted by -154bps to 1.66% in 2022, then crashed by -2396bps to 41.38% in 2023, then skyrocketed by 117bps to 6.83% in 2024, then skyrocketed by 239bps to 23.17% in 2025.
  • Business Quant data shows EBT Margin for OPRX at 23.17% in Q4 2025, 4.02% in Q3 2025, and 5.87% in Q2 2025.